In previous studies, LGALS2 was shown to be involved in tumor immunity48, thus we investigated the relationship between LGALS2 expression in the TCGA dataset and immune checkpoints, including CD200R1, CD47, CTLA4, TIM-3, PD-1, TIGIT, HVEM and CD69. Here, CD47 is linked to neoplasm.